Castleview Partners’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-6,665
Closed -$210K 240
2026
Q1
$210K Buy
+6,665
New +$210K 0.11% 184
2025
Q1
Sell
-6,963
Closed -$175K 473
2024
Q4
$175K Sell
6,963
-132
-2% -$3.35K 0.09% 200
2024
Q3
$177K Buy
+7,095
New +$210K 0.1% 182

Other funds holding RTO

Castleview Partners's RTO Position: Q2 2026 in Review

Castleview Partners sold out of Rentokil (RTO) in Q2 2026, closing a stake of 6,665 shares — an estimated $210K sold.

Castleview Partners first reported a position in RTO in Q3 2024 and held it in 3 quarters. The position peaked at $210K in Q1 2026. 30 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • Castleview Partners reported no remaining Rentokil position as of Q2 2026 after selling out during the quarter.
  • Castleview Partners sold 6,665 Rentokil shares in Q2 2026, an estimated $210K.
  • Castleview Partners first reported a position in Rentokil in Q3 2024 and held it in 3 quarters.
  • Castleview Partners's Rentokil position peaked at $210K in Q1 2026.
  • 30 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Castleview Partners's 13F filing for Q2 2026, filed 20 Jul 2026.